|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: TMOD1 |
Gene summary for TMOD1 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | TMOD1 | Gene ID | 7111 |
| Gene name | tropomodulin 1 | |
| Gene Alias | D9S57E | |
| Cytomap | 9q22.33 | |
| Gene Type | protein-coding | GO ID | GO:0001654 | UniProtAcc | P28289 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 7111 | TMOD1 | HTA11_4255_2000001011 | Human | Colorectum | SER | 3.03e-06 | 3.30e-01 | 0.0446 |
| 7111 | TMOD1 | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.95e-07 | 2.81e-01 | 0.0528 |
| 7111 | TMOD1 | HTA11_7663_2000001011 | Human | Colorectum | SER | 6.29e-03 | 2.25e-01 | 0.0131 |
| 7111 | TMOD1 | HTA11_10623_2000001011 | Human | Colorectum | AD | 8.98e-03 | 1.61e-01 | -0.0177 |
| 7111 | TMOD1 | HTA11_6818_2000001011 | Human | Colorectum | AD | 6.21e-21 | 8.35e-01 | 0.0112 |
| 7111 | TMOD1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.82e-03 | 1.05e-01 | 0.3859 |
| 7111 | TMOD1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 2.24e-13 | 2.34e-01 | 0.3005 |
| 7111 | TMOD1 | HTA12-15-2 | Human | Pancreas | PDAC | 4.58e-06 | 5.74e-01 | 0.2315 |
| 7111 | TMOD1 | HTA12-23-1 | Human | Pancreas | PDAC | 3.96e-05 | 6.36e-01 | 0.3405 |
| 7111 | TMOD1 | HTA12-25-1 | Human | Pancreas | PDAC | 2.48e-10 | 8.24e-01 | 0.313 |
| 7111 | TMOD1 | HTA12-26-1 | Human | Pancreas | PDAC | 3.69e-12 | 6.32e-01 | 0.3728 |
| 7111 | TMOD1 | HTA12-29-1 | Human | Pancreas | PDAC | 2.01e-48 | 9.76e-01 | 0.3722 |
| 7111 | TMOD1 | HTA12-30-1 | Human | Pancreas | PDAC | 4.45e-02 | 8.25e-01 | 0.3671 |
| 7111 | TMOD1 | HTA12-32-1 | Human | Pancreas | PDAC | 1.09e-02 | 8.55e-01 | 0.3624 |
| Page: 1 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:0007015 | Colorectum | AD | actin filament organization | 167/3918 | 442/18723 | 1.65e-16 | 7.94e-14 | 167 |
| GO:0032535 | Colorectum | AD | regulation of cellular component size | 142/3918 | 383/18723 | 1.74e-13 | 3.41e-11 | 142 |
| GO:1902903 | Colorectum | AD | regulation of supramolecular fiber organization | 139/3918 | 383/18723 | 2.01e-12 | 3.19e-10 | 139 |
| GO:0032970 | Colorectum | AD | regulation of actin filament-based process | 142/3918 | 397/18723 | 4.05e-12 | 5.90e-10 | 142 |
| GO:0110053 | Colorectum | AD | regulation of actin filament organization | 108/3918 | 278/18723 | 5.02e-12 | 6.98e-10 | 108 |
| GO:0008154 | Colorectum | AD | actin polymerization or depolymerization | 90/3918 | 218/18723 | 6.14e-12 | 8.23e-10 | 90 |
| GO:0032271 | Colorectum | AD | regulation of protein polymerization | 94/3918 | 233/18723 | 1.01e-11 | 1.29e-09 | 94 |
| GO:0030041 | Colorectum | AD | actin filament polymerization | 81/3918 | 191/18723 | 1.35e-11 | 1.69e-09 | 81 |
| GO:0051258 | Colorectum | AD | protein polymerization | 112/3918 | 297/18723 | 1.85e-11 | 2.27e-09 | 112 |
| GO:0043254 | Colorectum | AD | regulation of protein-containing complex assembly | 148/3918 | 428/18723 | 2.64e-11 | 3.18e-09 | 148 |
| GO:0002064 | Colorectum | AD | epithelial cell development | 89/3918 | 220/18723 | 2.98e-11 | 3.52e-09 | 89 |
| GO:0008064 | Colorectum | AD | regulation of actin polymerization or depolymerization | 79/3918 | 188/18723 | 4.17e-11 | 4.74e-09 | 79 |
| GO:0030833 | Colorectum | AD | regulation of actin filament polymerization | 74/3918 | 172/18723 | 4.50e-11 | 5.03e-09 | 74 |
| GO:0030832 | Colorectum | AD | regulation of actin filament length | 79/3918 | 189/18723 | 5.71e-11 | 6.27e-09 | 79 |
| GO:0032956 | Colorectum | AD | regulation of actin cytoskeleton organization | 127/3918 | 358/18723 | 1.03e-10 | 1.04e-08 | 127 |
| GO:0022411 | Colorectum | AD | cellular component disassembly | 147/3918 | 443/18723 | 8.53e-10 | 6.76e-08 | 147 |
| GO:0032984 | Colorectum | AD | protein-containing complex disassembly | 81/3918 | 224/18723 | 9.41e-08 | 4.65e-06 | 81 |
| GO:0010639 | Colorectum | AD | negative regulation of organelle organization | 114/3918 | 348/18723 | 1.41e-07 | 6.49e-06 | 114 |
| GO:0032272 | Colorectum | AD | negative regulation of protein polymerization | 36/3918 | 80/18723 | 1.13e-06 | 3.72e-05 | 36 |
| GO:0030837 | Colorectum | AD | negative regulation of actin filament polymerization | 30/3918 | 65/18723 | 4.59e-06 | 1.22e-04 | 30 |
| Page: 1 2 3 4 5 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| TMOD1 | SNV | Missense_Mutation | c.199C>A | p.Leu67Ile | p.L67I | P28289 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-BH-A0E7-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | |
| TMOD1 | SNV | Missense_Mutation | c.724N>C | p.Tyr242His | p.Y242H | P28289 | protein_coding | tolerated(0.54) | benign(0) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| TMOD1 | SNV | Missense_Mutation | rs767885123 | c.718N>A | p.Val240Met | p.V240M | P28289 | protein_coding | deleterious(0.04) | possibly_damaging(0.761) | TCGA-EK-A2PG-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD |
| TMOD1 | SNV | Missense_Mutation | novel | c.895N>A | p.Glu299Lys | p.E299K | P28289 | protein_coding | deleterious(0.01) | probably_damaging(0.998) | TCGA-VS-A959-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD |
| TMOD1 | SNV | Missense_Mutation | rs771595062 | c.398N>T | p.Ala133Val | p.A133V | P28289 | protein_coding | deleterious(0) | probably_damaging(0.938) | TCGA-AA-3971-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folinic | CR |
| TMOD1 | SNV | Missense_Mutation | rs770906034 | c.178G>A | p.Gly60Ser | p.G60S | P28289 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-AA-A00N-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
| TMOD1 | SNV | Missense_Mutation | rs760447981 | c.341C>T | p.Pro114Leu | p.P114L | P28289 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AA-A01D-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | capecitabine | PD |
| TMOD1 | SNV | Missense_Mutation | novel | c.460T>C | p.Ser154Pro | p.S154P | P28289 | protein_coding | tolerated(0.11) | benign(0.071) | TCGA-AY-6196-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
| TMOD1 | SNV | Missense_Mutation | c.247N>T | p.Asp83Tyr | p.D83Y | P28289 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-AY-A69D-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
| TMOD1 | SNV | Missense_Mutation | novel | c.24G>T | p.Glu8Asp | p.E8D | P28289 | protein_coding | tolerated(0.18) | benign(0.191) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
| Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |